Tvardi Therapeutics, Inc. (FRA:69C)
Germany flag Germany · Delayed Price · Currency is EUR
3.065
+0.310 (11.25%)
Last updated: Nov 27, 2025, 8:02 AM CET

Tvardi Therapeutics Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.01-5.430.020.01
Quick Ratio
3.303.056.9910.23
Current Ratio
3.483.067.9710.31
Return on Equity (ROE)
-135.64%-329.99%-54.30%-
Return on Assets (ROA)
-72.68%-56.48%-32.36%-
Return on Capital (ROIC)
-105.82%-72.07%-36.05%-
Return on Capital Employed (ROCE)
-107.10%-113.20%-78.70%-51.90%
Buyback Yield / Dilution
-170.52%-0.31%-0.09%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.